| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2078206 | Cell Stem Cell | 2009 | 4 Pages |
Abstract
Human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) can theoretically be converted into any somatic cell type. hESCs and hiPSCs carrying genetic defects can now be produced to model diseases in vitro. We suggest several guiding principles to help ensure an optimal fit between technology and disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Alan Colman, Oliver Dreesen,